Lymphoma Clinical Trials in Massachusetts

Showing 241-260 of 455 trials

Therapy for Pediatric Hodgkin Lymphoma

NCT00145600

With the success of current chemotherapy for Hodgkin's disease, the goal of this protocol is to maintain the currently successful cure rate and reduce treatment related side effects and long term toxicity. The main purpose of this study is to estimate the event free survival of patients treated with risk-adapted therapy compared to historical controls.

Hodgkin Lymphoma

St. Jude Children's Research Hospital296 participantsStarted Mar 2000

Palo Alto, California, United States • Portland, Maine, United States • Boston, Massachusetts, United States +2 more locations

COMPLETEDPhase 126 miles

A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

NCT02395601

First in human, open-label, sequential dose escalation and expansion study of CPI-1205 in patients with progressive B-cell lymphomas. CPI-1205 is a small molecule inhibitor of EZH2.

B-Cell Lymphoma

Constellation Pharmaceuticals41 participantsStarted Mar 2015

Lafayette, Indiana, United States • Boston, Massachusetts, United States • Omaha, Nebraska, United States +3 more locations

Therapy for Pediatric Hodgkin Lymphoma

A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas

Lymphoma Trials in Other Cities

Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.

A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies

Double Cord Versus Haploidentical (BMT CTN 1101)

Response-Based Therapy Assessed By PET Scan in Treating Patients With Bulky Stage I and Stage II Classical Hodgkin Lymphoma

ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas

Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy

Lenalidomide Monotherapy in R/R DLBCL

Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

A Study of LY3023414 in Participants With Advanced Cancer

A Study of Obinutuzumab in Combination With Idasanutlin and Venetoclax in Participants With Relapsed or Refractory (R/R) Follicular Lymphoma (FL) or Rituximab in Combination With Idasanutlin and Venetoclax in Participants With R/R Diffuse Large B-Cell Lymphoma (DLBCL)

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

Study of the Safety and Efficacy of MIW815 With PDR001 in Patients With Advanced/Metastatic Solid Tumors or Lymphomas

Study to Assess if ABP798 is Safe & Effective in Treating Non Hodgkin Lymphoma Compared to Rituximab

A Study of GDC-0853 in Patients With Resistant B-Cell Lymphoma or Chronic Lymphocytic Leukemia.

Study to Evaluate Safety and Preliminary Efficacy of Tafasitamab With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi

Other Conditions in Massachusetts